Literature DB >> 27761718

Gene migration for re-emerging amebiasis in Iran's northwest-Iraq borders: a microevolutionary scale for reflecting epidemiological drift of Entamoeba histolytica metapopulations.

Asad Mohammadzadeh1,2, Adel Spotin3,4, Mahmoud Mahami-Oskouei2, Ali Haghighi5, Nozhat Zebardast6, Kobra Kohansal7.   

Abstract

In the microevolutionary scales of Entamoeba isolates, the gene migration shows how Entamoeba spp. has epidemiologically drifted among border countries. Five hundred fecal samples were taken from patients suffering gastrointestinal disorders, abdominal pain, and diarrhea at Saggez, northwest Iran located within the border Iraq country. Following parasitological techniques, DNA samples were extracted and amplified by polymerase chain reaction (PCR) of 18S rRNA region to identify Entamoeba infections. To distinguish the Entamoeba spp., a multiplex PCR was conducted. Amplicons were sequenced to reconfirm their heterogeneity traits and phylogenetic analysis. Additionally, Entamoeba histolytica sequences of Iraq were retrieved from GenBank database. The suspected isolates were diagnosed as E. histolytica (2.2 %), Entamoeba moshkovskii (1 %), and Entamoeba dispar (0.4 %). Mixed Entamoeba infections did not detect among isolates. A parsimonious network of the sequence haplotypes displayed star-like features in the overall isolates containing E.h1, E.d2, and E.m3 as the most common haplotypes. According to analysis of molecular variance (AMOVA) test, high partial value of haplotype diversity (0.700 to 0.800) of E. histolytica was shown the total genetic variability within populations while nucleotide diversity was low among Iranian and Iraqi metapopulations. Neutrality indices of the 18S rRNA were shown negative values in E. histolytica populations which indicating significant deviations from neutrality. A pairwise fixation index (F-statistics [Fst]) as a degree of gene flow had a low value for all populations (0.001) while the number of migrants was 2.48. The statistically Fst value indicates that E. histolytica isolates are not genetically differentiated among shared isolates of Iran and Iraq. Occurrence of E.h1 between two regional populations indicates that there is dawn of Entamoeba flow due to transfer of alleles from one population to another population through host mobility and ecological alterations. To evaluate the hypothetical evolutionary scenario, further study is required to analyze Entamoeba spp. in the neighboring Middle East countries.

Entities:  

Keywords:  Entamoeba spp.; Fst; Gene flow; Iraq; Northwest Iran

Mesh:

Year:  2016        PMID: 27761718     DOI: 10.1007/s00436-016-5282-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  28 in total

1.  Comparison of a stool antigen detection kit and PCR for diagnosis of Entamoeba histolytica and Entamoeba dispar infections in asymptomatic cyst passers in Iran.

Authors:  Shahram Solaymani-Mohammadi; Mostafa Rezaian; Zahra Babaei; Azam Rajabpour; Ahmad R Meamar; Ahmad A Pourbabai; William A Petri
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  Speciation in parasites: a population genetics approach.

Authors:  Tine Huyse; Robert Poulin; André Théron
Journal:  Trends Parasitol       Date:  2005-10

3.  Molecular variation in Leishmania parasites from sandflies species of a zoonotic cutaneous leishmaniasis in northeast of Iran.

Authors:  Mitra Sharbatkhori; Adel Spotin; Heshmatollah Taherkhani; Mona Roshanghalb; Parviz Parvizi
Journal:  J Vector Borne Dis       Date:  2014-03       Impact factor: 1.688

4.  Entamoeba moshkovskii and Entamoeba dispar-associated infections in pondicherry, India.

Authors:  Subhash Chandra Parija; Krishna Khairnar
Journal:  J Health Popul Nutr       Date:  2005-09       Impact factor: 2.000

5.  Molecular epidemiology of amebiasis.

Authors:  Ibne Karim M Ali; C Graham Clark; William A Petri
Journal:  Infect Genet Evol       Date:  2008-05-14       Impact factor: 3.342

6.  Molecular differentiation of Entamoeba histolytica and Entamoeba dispar from Tunisian food handlers with amoeba infection initially diagnosed by microscopy.

Authors:  S Ben Ayed; Abdallah R Ben; M Mousli; K Aoun; M Thellier; A Bouratbine
Journal:  Parasite       Date:  2008-03       Impact factor: 3.000

Review 7.  Reassessment of the epidemiology of amebiasis: state of the art.

Authors:  Cecilia Ximénez; Patricia Morán; Liliana Rojas; Alicia Valadez; Alejandro Gómez
Journal:  Infect Genet Evol       Date:  2009-06-18       Impact factor: 3.342

8.  Differential identification of Entamoeba spp. based on the analysis of 18S rRNA.

Authors:  Helena Lúcia Carneiro Santos; Rebecca Bandea; Luci Ana Fernandes Martins; Heloisa Werneck de Macedo; Regina Helena Saramago Peralta; Jose Mauro Peralta; Mackevin I Ndubuisi; Alexandre J da Silva
Journal:  Parasitol Res       Date:  2010-02-19       Impact factor: 2.289

9.  Entamoeba moshkovskii infections in children, Bangladesh.

Authors:  Ibne Karim M Ali; Mohammad Bakhtiar Hossain; Shantanu Roy; Patrick F Ayeh-Kumi; William A Petri; Rashidul Haque; C Graham Clark
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

10.  A novel nested multiplex polymerase chain reaction (PCR) assay for differential detection of Entamoeba histolytica, E. moshkovskii and E. dispar DNA in stool samples.

Authors:  Krishna Khairnar; Subhash C Parija
Journal:  BMC Microbiol       Date:  2007-05-24       Impact factor: 3.605

View more
  2 in total

1.  Differential detection of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in faecal samples using nested multiplex PCR in west of Iran.

Authors:  Fares Bahrami; Ali Haghighi; Ghasem Zamini; Mohammadbagher Khademerfan
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

2.  Amoebiasis in Iran: a systematic review and meta-analysis.

Authors:  Ali Haghighi; Seyed Mohammad Riahi; Ali Taghipour; Adel Spotin; Mostafa Javanian; Mohsen Mohammadi; Mohammadreza Esmaeili Dooki; Ali Rostami
Journal:  Epidemiol Infect       Date:  2018-07-11       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.